MANAGEMENT AND TREATMENT OF GLOMERULAR DISEASES (PART 1): CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline’s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

Cite

CITATION STYLE

APA

Floege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., … Rovin, B. H. (2020). MANAGEMENT AND TREATMENT OF GLOMERULAR DISEASES (PART 1): CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE. In Nephrology (Saint-Petersburg) (Vol. 24, pp. 22–41). Educational Autonomous Non-Profit Organization Nephrology. https://doi.org/10.36485/1561-6274-2020-24-2-22-41

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free